Literature DB >> 1190928

Preventive effect of estrogen on postmenopausal bone loss.

S Meema, M L Bunker, H E Meema.   

Abstract

Follow-up studies of bone mineral content in the radius were done in 82 postmenopausal women 4 to 10 years after the first examination. These patients were subdivided into four groups depending on the type of menopause (artificial or natural) and estrogen administration (treated or untreated). Bone mineral mass and combined cortical thickness decreased significantly in both groups of untreated women. Both mineral loss per year for the untreated women was -9.1 mg/sq cm for castrates and -6.9 mg/sq cm for those with a natural menopause. In neither group was the rate of loss correlated with age. The change in bone mineral mass per year in the estrogen-treated subjects (mean +3.25 mg/sq cm) differed significantly from that of untreated subjects (mean -7.99 mg/sq cm). The findings suggest that postmenopausal osteoporosis could be prevented by estrogen treatment.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1190928

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  22 in total

1.  Effect of sex steroids on bone collagen synthesis in vitro.

Authors:  E Canalis; L G Raisz
Journal:  Calcif Tissue Res       Date:  1978-05-26

2.  [Not Available].

Authors:  J E Rioux
Journal:  Can Fam Physician       Date:  1983-04       Impact factor: 3.275

3.  Effects of ovariectomy on iliac trabecular bone in baboons (Papio anubis).

Authors:  C P Jerome; D B Kimmel; J A McAlister; D S Weaver
Journal:  Calcif Tissue Int       Date:  1986-09       Impact factor: 4.333

4.  Smoker's bones.

Authors: 
Journal:  Br Med J       Date:  1976-07-24

5.  The climacteric syndrome: an estrogen replacement dilemma.

Authors:  R C Strickler; R Borth; C A Woodlever
Journal:  Can Med Assoc J       Date:  1977-03-19       Impact factor: 8.262

6.  Effect of oestrogens on postmenopausal bone loss.

Authors:  R Lindsay; D M Hart
Journal:  Br Med J       Date:  1977-10-22

7.  The treatment of metabolic bone disease.

Authors:  S Posen; P Clifton-Bligh; R S Mason
Journal:  Drugs       Date:  1979-04       Impact factor: 9.546

8.  Hospitalization for fractures and bone loss in adults. Why do we regard these phenomena as dull?

Authors:  C M Wylie
Journal:  Public Health Rep       Date:  1977 Jan-Feb       Impact factor: 2.792

9.  Influence of estrogen and progesterone on matrix-induced endochondral bone formation.

Authors:  C C Burnett; A H Reddi
Journal:  Calcif Tissue Int       Date:  1983-07       Impact factor: 4.333

10.  Thyroid supplements: effect on bone mass.

Authors:  B Ettinger; J Wingerd
Journal:  West J Med       Date:  1982-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.